Publications by authors named "Robin Parihar"

Claim this Profile
T
TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength.
Ishwar Navin, Matthew Dysthe, Prashant S Menon, Corrine Baumgartner, Tim Sauer, Robin Parihar

Cancer Immunol Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive IL-7 signaling promotes CAR-NK cell survival in the solid tumor microenvironment but impairs tumor control.
Matthew Dysthe, Ishwar Navin, Dayenne van Leeuwen, Josue Pineda, Corrine Baumgartner, Robin Parihar

J Immunother Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma.
Greyson Biegert, Amanda Rosewell Shaw, Daisuke Morita, Caroline Porter, Ryu Matsumoto, Robin Parihar

Mol Ther Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition.
Stephanie L Fetzko, Leander D Timothy, Robin Parihar

Curr Hematol Malig Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory NK cells to forget relapsed AML.
Robin Parihar

Blood· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer.
Saisha A Nalawade, Paul Shafer, Pradip Bajgain, Mary K McKenna, Arushana Ali, Robin Parihar

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic adeno-immunotherapy modulates the immune system enabling CAR T-cells to cure pancreatic tumors.
Amanda Rosewell Shaw, Caroline E Porter, Tiffany Yip, Way-Champ Mah, Mary K McKenna, Robin Parihar

Commun Biol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment.
Ishwar Navin, Michael T Lam, Robin Parihar

Cancers (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics.
Laxman Devkota, Zbigniew Starosolski, Charlotte H Rivas, Igor Stupin, Ananth Annapragada, Robin Parihar

Sci Adv· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Matthew Dysthe, Robin Parihar

Adv Exp Med Biol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors.
Robin Parihar, Charlotte Rivas, Mai Huynh, Bilal Omer, Natalia Lapteva

Cancer Immunol Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells.
Bilal Omer, Paul A Castillo, Haruko Tashiro, Thomas Shum, Mai T A Huynh, Robin Parihar

Front Med (Lausanne)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy.
Padmini Jayaraman, Falguni Parikh, Jared M Newton, Aurelie Hanoteau, Charlotte Rivas, Robin Parihar

Oncoimmunology· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy.
Natalia Lapteva, Robin Parihar, Lisa A Rollins, Adrian P Gee, Cliona M Rooney

Methods Mol Biol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells.
Thomas Shum, Bilal Omer, Haruko Tashiro, Robert L Kruse, Dimitrios L Wagner, Robin Parihar

Cancer Discov· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.
Amanda R Campbell, Megan C Duggan, Lorena P Suarez-Kelly, Neela Bhave, Kallan S Opheim, Robin Parihar

Cancer Immunol Res· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?
Robin Parihar

Mol Ther· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of the human natural killer cell response to Fc receptor activation: unique enhancement in the presence of interleukin-12.
Amanda R Campbell, Kelly Regan, Neela Bhave, Arka Pattanayak, Robin Parihar

BMC Med Genomics· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-12 enhances the antitumor actions of trastuzumab via NK cell IFN-γ production.
Alena Cristina Jaime-Ramirez, Bethany L Mundy-Bosse, SriVidya Kondadasula, Natalie B Jones, Julie M Roda, Robin Parihar

J Immunol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma.
Sri Vidya Kondadasula, Julie M Roda, Robin Parihar, Jianhua Yu, Amy Lehman

Blood· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-21 enhances NK cell activation in response to antibody-coated targets.
Julie M Roda, Robin Parihar, Amy Lehman, Aruna Mani, Susheela Tridandapani

J Immunol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.
Julie M Roda, Robin Parihar, Cynthia Magro, Gerard J Nuovo, Susheela Tridandapani

Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the sequential combination of interleukin-12 and interferon alfa-2b in advanced cancer: evidence for modulation of interferon signaling pathways by interleukin-12.
Charles F Eisenbeis, Gregory B Lesinski, Mirela Anghelina, Robin Parihar, Daniel Valentino

J Clin Oncol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel cytokines in the treatment of malignancies.
Robin Parihar, William E Carson

Cancer Treat Res· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
Robin Parihar, Rossana Trotta, Julie M Roda, Amy K Ferketich, Susheela Tridandapani

Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis